The Ability of the General Male Public to Assess Their Suitability to Take 50-mg Sildenafil: An Assessment of the Comprehension of Patient Information Materials via Internet Survey
- 1 July 2011
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 8 (7) , 2038-2047
Abstract
Introduction: Erectile dysfunction (ED) is the most common male sexual dysfunction and has a negative impact on masculinity and self-esteem. Phosphodiesterase type 5 inhibitors, including sildenafil, are the first-line treatment option for ED. Providing appropriate information regarding suitability for using sildenafil is important. Aim: The purpose of this study was to assess whether a broad spectrum of men could appropriately evaluate their suitability for 50-mg sildenafil after reviewing patient information materials. Main Outcome Measures: Patient information (Pack) on appropriate use of 50-mg sildenafil and patient information leaflet (PIL), a Web survey including demographics, self-assessed suitability for sildenafil use, and suitability screener. Methods: A randomly selected, population-representative Web-based panel of males in the UK was recruited for this study. Eligible men answered a brief sociodemographic questionnaire and then were presented with the Pack. If a participant desired additional information, he could also review the PIL. The participants then rated the Pack and PIL (if reviewed), self-assessed their suitability for sildenafil use, and completed a previously validated screener for suitability. Results: A total of 1,275 men aged 40 and above were included in these analyses; the mean age was 57.8 ± 9.9 years. A total of 1,054 men reported ED; 517 men (40.5%) deemed themselves suitable for sildenafil; 504 men (39.6%) deemed themselves unsuitable; and 254 (19.9%) were unsure. The concordance rate between screener-assessed suitability and self-assessed suitability was 70.9% (95% confidence interval [CI] = 68.1–73.7%). When accounting for men who would not take sildenafil even though they were suitable or would seek additional information from a healthcare professional prior to using sildenafil, the concordance rate was 84.2% (95% CI = 82.2–86.2%). Conclusion: The results of this study suggest that men in the general population are capable of using written sildenafil patient education materials to accurately assess their suitability for treatment with 50-mg sildenafil.Keywords
This publication has 32 references indexed in Scilit:
- The Ability of Men to Assess their Suitability to Take a Phosphodiesterase Type 5 Inhibitor: An Assessment of the Comprehension of Patient Information MaterialsThe Journal of Sexual Medicine, 2010
- Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature EjaculationEuropean Urology, 2010
- Co-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitratesCurrent Medical Research and Opinion, 2010
- Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety databaseInternational Journal Of Clinical Practice, 2009
- Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysisAnnals of Internal Medicine, 2009
- Improving Patient Understanding of Prescription Drug Label InstructionsJournal of General Internal Medicine, 2008
- Analysis of single items on the Self‐Esteem And Relationship questionnaire in men treated with sildenafil citrate for erectile dysfunction: results of two double‐blind, placebo‐controlled trialsBJU International, 2008
- CHAPTER 1: THE MANAGEMENT OF ERECTILE DYSFUNCTION: AN AUA UPDATEJournal of Urology, 2005
- Psychological Impact of Erectile Dysfunction: Validation of a New Health Related Quality of Life Measure for Patients With Erectile DysfunctionJournal of Urology, 2002
- The Dutch cohort of sildenafil users: baseline characteristicsBJU International, 2001